Medical Conditions Among Adult Offspring Prenatally Exposed to Diethylstilbestrol | Zendy

Rebecca Troisi | Zendy; Marianne Hyer | Zendy; Elizabeth E. Hatch | Zendy; Linda TitusErnstoff | Zendy; Julie R. Palmer | Zendy; William C. Strohsnitter | Zendy; Arthur L. Herbst | Zendy; Ervin Adam | Zendy; Robert N. Hoover | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Medical Conditions Among Adult Offspring Prenatally Exposed to Diethylstilbestrol

Author(s) -

Rebecca Troisi,

Marianne Hyer,

Elizabeth E. Hatch,

Linda TitusErnstoff,

Julie R. Palmer,

William C. Strohsnitter,

Arthur L. Herbst,

Ervin Adam,

Robert N. Hoover

Publication year - 2013

Publication title -

epidemiology

Language(s) - Uncategorized

Resource type - Journals

SCImago Journal Rank - 1.901

H-Index - 173

eISSN - 1531-5487

pISSN - 1044-3983

DOI - 10.1097/ede.0b013e318289bdf7

Subject(s) - medicine , offspring , pregnancy , osteoporosis , hazard ratio , body mass index , obstetrics , physiology , diabetes mellitus , confidence interval , gynecology , endocrinology , biology , genetics

Diethylstilbestrol (DES), a synthetic estrogen that was used in pregnancy, is a prototype endocrine-disrupting chemical. Although prenatal exposure to DES is known to increase risks of vaginal/cervical adenocarcinoma and adverse reproductive outcomes in women, and urogenital anomalies in men, data on nonreproductive medical conditions are lacking.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research